Nuvation Bio IncNYSE:NUVB
- LAST PRICE2.9200
- TODAY'S CHANGE (%)-0.1200 (-3.9474%)
- Bid / Lots2.9500/ 10
- Ask / Lots2.9700/ 1
- Open / Previous Close3.0800 / 3.0400
- Day Range
- 52 Week Range
- Volume10,428,534
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVB |
|---|---|---|
| 09:32 ET | 6164 | 3.06 |
| 09:34 ET | 22293 | 3.055 |
| 09:36 ET | 25643 | 3.0791 |
| 09:38 ET | 34803 | 3.11 |
| 09:39 ET | 38810 | 3.145 |
| 09:41 ET | 45092 | 3.145 |
| 09:43 ET | 24375 | 3.145 |
| 09:45 ET | 17568 | 3.14 |
| 09:48 ET | 27054 | 3.12 |
| 09:50 ET | 21264 | 3.135 |
| 09:52 ET | 26693 | 3.125 |
| 09:54 ET | 14608 | 3.1189 |
| 09:56 ET | 15437 | 3.1599 |
| 09:57 ET | 38214 | 3.175 |
| 09:59 ET | 17173 | 3.175 |
| 10:01 ET | 15676 | 3.155 |
| 10:03 ET | 24995 | 3.13 |
| 10:06 ET | 16242 | 3.12 |
| 10:08 ET | 51732 | 3.0806 |
| 10:10 ET | 17395 | 3.1 |
| 10:12 ET | 10864 | 3.12 |
| 10:14 ET | 9023 | 3.105 |
| 10:15 ET | 8109 | 3.1 |
| 10:17 ET | 24205 | 3.1 |
| 10:19 ET | 15009 | 3.095 |
| 10:21 ET | 1807 | 3.0982 |
| 10:24 ET | 4230 | 3.095 |
| 10:26 ET | 22083 | 3.105 |
| 10:28 ET | 36467 | 3.125 |
| 10:30 ET | 10482 | 3.1198 |
| 10:32 ET | 8818 | 3.1 |
| 10:33 ET | 5184 | 3.09 |
| 10:35 ET | 5700 | 3.08 |
| 10:37 ET | 15778 | 3.095 |
| 10:39 ET | 7713 | 3.0899 |
| 10:42 ET | 8837 | 3.1 |
| 10:44 ET | 12840 | 3.1 |
| 10:46 ET | 9498 | 3.11 |
| 10:48 ET | 6796 | 3.105 |
| 10:50 ET | 16734 | 3.115 |
| 10:51 ET | 3433 | 3.115 |
| 10:53 ET | 15774 | 3.115 |
| 10:55 ET | 2492 | 3.115 |
| 10:57 ET | 12705 | 3.105 |
| 11:00 ET | 5112 | 3.105 |
| 11:02 ET | 12763 | 3.095 |
| 11:04 ET | 7278 | 3.105 |
| 11:06 ET | 621 | 3.1 |
| 11:08 ET | 4904 | 3.105 |
| 11:09 ET | 9899 | 3.1 |
| 11:11 ET | 5614 | 3.085 |
| 11:13 ET | 19816 | 3.1 |
| 11:15 ET | 5684 | 3.105 |
| 11:18 ET | 8231 | 3.1 |
| 11:20 ET | 1000 | 3.1 |
| 11:22 ET | 2762 | 3.1061 |
| 11:24 ET | 5307 | 3.105 |
| 11:26 ET | 1630 | 3.105 |
| 11:27 ET | 19495 | 3.12 |
| 11:29 ET | 3100 | 3.115 |
| 11:31 ET | 9910 | 3.115 |
| 11:33 ET | 3155 | 3.115 |
| 11:36 ET | 9957 | 3.115 |
| 11:38 ET | 8824 | 3.11 |
| 11:40 ET | 29476 | 3.1145 |
| 11:42 ET | 3941 | 3.115 |
| 11:44 ET | 2250 | 3.115 |
| 11:45 ET | 11131 | 3.115 |
| 11:47 ET | 1500 | 3.115 |
| 11:49 ET | 6250 | 3.115 |
| 11:51 ET | 4097 | 3.115 |
| 11:54 ET | 8366 | 3.115 |
| 11:56 ET | 25288 | 3.15 |
| 11:58 ET | 19407 | 3.155 |
| 12:00 ET | 5727 | 3.145 |
| 12:02 ET | 12603 | 3.145 |
| 12:03 ET | 19110 | 3.15 |
| 12:05 ET | 2111 | 3.155 |
| 12:07 ET | 1611 | 3.155 |
| 12:09 ET | 10204 | 3.145 |
| 12:12 ET | 1900 | 3.1499 |
| 12:14 ET | 1500 | 3.145 |
| 12:16 ET | 10140 | 3.15 |
| 12:18 ET | 1851 | 3.15 |
| 12:20 ET | 9616 | 3.155 |
| 12:21 ET | 36333 | 3.16 |
| 12:23 ET | 9349 | 3.175 |
| 12:25 ET | 12897 | 3.175 |
| 12:27 ET | 26964 | 3.175 |
| 12:30 ET | 498 | 3.175 |
| 12:32 ET | 2683 | 3.175 |
| 12:34 ET | 2260 | 3.18 |
| 12:36 ET | 1803 | 3.175 |
| 12:38 ET | 11011 | 3.185 |
| 12:39 ET | 2235 | 3.1899 |
| 12:41 ET | 17911 | 3.185 |
| 12:43 ET | 2600 | 3.185 |
| 12:45 ET | 2546 | 3.185 |
| 12:48 ET | 600 | 3.185 |
| 12:50 ET | 7308 | 3.195 |
| 12:52 ET | 6781 | 3.21 |
| 12:54 ET | 1800 | 3.21 |
| 12:56 ET | 4031 | 3.205 |
| 12:57 ET | 40544 | 3.175 |
| 12:59 ET | 700 | 3.175 |
| 01:01 ET | 10170 | 3.16 |
| 01:03 ET | 3700 | 3.165 |
| 01:06 ET | 800 | 3.16 |
| 01:08 ET | 15248 | 3.175 |
| 01:10 ET | 8757 | 3.18 |
| 01:12 ET | 8123 | 3.195 |
| 01:14 ET | 1562 | 3.195 |
| 01:15 ET | 3339 | 3.19 |
| 01:17 ET | 900 | 3.195 |
| 01:19 ET | 3207 | 3.195 |
| 01:21 ET | 3823 | 3.195 |
| 01:24 ET | 48530 | 3.195 |
| 01:26 ET | 1400 | 3.19 |
| 01:28 ET | 15300 | 3.185 |
| 01:30 ET | 25168 | 3.175 |
| 01:32 ET | 6311 | 3.18 |
| 01:33 ET | 12100 | 3.1739 |
| 01:35 ET | 11227 | 3.1501 |
| 01:37 ET | 29415 | 3.16 |
| 01:39 ET | 8200 | 3.164 |
| 01:42 ET | 5002 | 3.165 |
| 01:44 ET | 1379 | 3.165 |
| 01:46 ET | 13530 | 3.16 |
| 01:48 ET | 2740 | 3.165 |
| 01:50 ET | 21681 | 3.16 |
| 01:51 ET | 8626 | 3.14 |
| 01:53 ET | 817 | 3.14 |
| 01:55 ET | 1600 | 3.145 |
| 01:57 ET | 10520 | 3.135 |
| 02:00 ET | 6510 | 3.135 |
| 02:02 ET | 500 | 3.135 |
| 02:04 ET | 700 | 3.135 |
| 02:06 ET | 900 | 3.135 |
| 02:08 ET | 3889 | 3.135 |
| 02:09 ET | 48505 | 3.135 |
| 02:11 ET | 3790 | 3.13 |
| 02:13 ET | 2000 | 3.135 |
| 02:15 ET | 1100 | 3.135 |
| 02:18 ET | 700 | 3.135 |
| 02:20 ET | 2825 | 3.14 |
| 02:22 ET | 20429 | 3.15 |
| 02:24 ET | 57975 | 3.125 |
| 02:26 ET | 5715 | 3.135 |
| 02:27 ET | 1002 | 3.13 |
| 02:29 ET | 1000 | 3.135 |
| 02:31 ET | 4723 | 3.135 |
| 02:33 ET | 25094 | 3.14 |
| 02:36 ET | 24393 | 3.14 |
| 02:38 ET | 5173 | 3.14 |
| 02:40 ET | 7860 | 3.135 |
| 02:42 ET | 16484 | 3.15 |
| 02:44 ET | 4415 | 3.145 |
| 02:45 ET | 700 | 3.145 |
| 02:47 ET | 1500 | 3.14 |
| 02:49 ET | 32566 | 3.135 |
| 02:51 ET | 1200 | 3.135 |
| 02:54 ET | 3108 | 3.135 |
| 02:56 ET | 34699 | 3.105 |
| 02:58 ET | 2400 | 3.1 |
| 03:00 ET | 16981 | 3.09 |
| 03:02 ET | 15400 | 3.075 |
| 03:03 ET | 52602 | 3.045 |
| 03:05 ET | 57564 | 3.05 |
| 03:07 ET | 20642 | 3.045 |
| 03:09 ET | 1540 | 3.045 |
| 03:12 ET | 2500 | 3.045 |
| 03:14 ET | 7070 | 3.05 |
| 03:16 ET | 25395 | 3.045 |
| 03:18 ET | 4155 | 3.045 |
| 03:20 ET | 6400 | 3.04 |
| 03:21 ET | 1580 | 3.045 |
| 03:23 ET | 23079 | 3.04 |
| 03:25 ET | 1335 | 3.045 |
| 03:27 ET | 3673 | 3.045 |
| 03:30 ET | 13727 | 3.045 |
| 03:32 ET | 42026 | 3.04 |
| 03:34 ET | 9110 | 3.035 |
| 03:36 ET | 21968 | 3.04 |
| 03:38 ET | 11651 | 3.035 |
| 03:39 ET | 27691 | 3.04 |
| 03:41 ET | 3536 | 3.045 |
| 03:43 ET | 20633 | 3.055 |
| 03:45 ET | 35190 | 3.05 |
| 03:48 ET | 121510 | 2.985 |
| 03:50 ET | 13881 | 2.985 |
| 03:52 ET | 47737 | 3.035 |
| 03:54 ET | 27550 | 3.035 |
| 03:56 ET | 142313 | 2.945 |
| 03:57 ET | 129928 | 2.955 |
| 03:59 ET | 186797 | 2.92 |
Jun 3, 2024
DJ Nuvation Bio Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 6:46AM ET on Monday Jun 03, 2024 by Dow Jones
6:46AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting, from 8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
May 29, 2024
Nuvation Bio to Present at the Jefferies Global Healthcare Conference, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones
4:05PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvation Bio Inc | 739.0M | -9.3x | --- |
89Bio Inc | 719.2M | -4.0x | --- |
Cogent Biosciences Inc | 774.5M | -3.4x | --- |
ARS Pharmaceuticals Inc | 782.9M | -16.4x | --- |
Viridian Therapeutics Inc | 785.7M | -2.9x | --- |
SS Innovations International Inc | 751.3M | -31.0x | --- |
Company Information
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Contact Information
- Headquarters
- 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
- Phone
- 415-754-3517
- Fax
- 302-636-5454
Executives
- Independent Chair of the Board
- Daniel Welch
- President, Chief Executive Officer, Founder, Director
- David Hung
- Principal Financial and Accounting Officer, Vice President - Finance
- Moses Makunje
- Chief Executive Officer of AnHeart Therapeutics and Director
- Junyuan Wang
- Chief People Officer
- Stacy Markel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $739.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.41 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -9.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
